APIQUEST USA CORPORATION
WORLD PERSPECTIVE
IMPORTANCE OF MEDICINAL PLANTS IN PRIMARY HEALTH CARE
According to World Health Organization (WHO) a vast majority of people (about 80%) in the developing world relies on herbal medicines for their primary healthcare needs. There are 89 plant-derived drugs currently prescribed in the industrialized world.
Why us?
Best lecturers
GAME CHANGER
The World Health Organization (WHO) said it was encouraging research into natural medicines in Africa against Covid-19 and other epidemics. EXPERTS from WHO and two other organizations have "approved a protocol for Phase 3 herbal medicine clinical trials for Covid-19,"
Career guarantee
MAJOR DILEMMA
International diploma
THE SOLUTION
PARADIGM SHIFT
Today, the world-wide health market is undergoing a product repolarization. 8 Million people are hospitalized each year for the ailments caused by the ingestion and side effects of prescription drugs. People are buying fewer pharmaceutical drugs and more health foods, preventive herbs and vitamins. Good herbal products have tendency to make people sick less often.
Modern studies
More acceptance for the phytotherapy. Use of biotechnology and genetic engineering for the production of plant-based medicines (Cell culture, targeted biosynthesis, etc.). Demand of plant-based medicines for age-related disease (autoimmune, and degenerative diseases). Preventive medicines (antioxidants, vaccines, nutritional therapy, etc.) will be more important. Many new diseases among the poorest due to microbial resistance and water shortage.
About us
OUR GOAL
APIQUEST-USA is a Delaware Corporation focused on solutions to eradicate the deadly COVID-19 pandemic and allow the USA and the world to go back to business as usual. To date, the virus has claimed over 790,000 US lives and more than 5,310,000 worldwide. APIQUEST-USA signed an exclusive agreement with Dr. Valentin Agon, a renowned African doctor and researcher, owner of APIVIRINE. This natural antiviral drug has proven to be useful with lots of deadly viruses, including COVID-19 and HIV-AIDS.
THE OPPORTINUTY
Over 25,000 flowering plants in the World, less than 2 percent, have been exhaustively studied for their potential pharmacological activities and bioactive chemical constituents.
Governments in developed countries, especially in Europe, have also been quick to consider the growing demand for herbal medicine and have funded significant research efforts to enhance the precision and sophistication of the area. It is likely to be a substantial driver for the Herbal Medicine Market over the forecast period. Government-funded clinical research facilities could provide a sophisticated, polished version of herbal medicine. Providing the customer with the best of both worlds, APIVIRINE fits in this category of medicinal plants. Africa’s pharmaceutical industry jumped to $20.8 billion in 2013 from just $4.7 billion a decade earlier.
THE STATISTIC
By 2026, the pharmaceutical market could represent a $411.2 billion opportunity for drug manufacturers, a 20.5% CAGR. Various factors such as low cost of the products, significantly less or no side effects of herbal medicine, rising usage by the global population, and ease of availability will further aid in the market growth over the forecast period.
As a result of the factors, Africa is on track to become the fastest growing pharmaceutical market in the world over the next decade.
APIQUEST USA intends to take advantage of that opportunity to bring to the US market life-saving drugs, whether natural or synthesized, to help save precious American lives.
